SCR-LIP-000150 · Claim · machine-readable JSON →
In a chart review of 46 women with lipedema (mean BMI 35.3 kg/m²), diabetes prevalence was 2% (vs 10.7% in similarly-aged general women), hypertension 0-25% across stages (vs 32.4% nationally), and dyslipidemia 11.7% (vs 33.5%), suggesting lipedema fat is associated with relatively reduced obesity-related metabolic dysfunction until late stages.
Created: 2026-05-31 · Last updated: 2026-05-31
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Lipedema: friend and foe — Torre et al. (2018) — supporting · case series · 2018
The article reports lower rates of diabetes, hypertension, and dyslipidemia in lipedema patients compared to general/obese female populations despite high BMI, directly supporting the metabolic-protection aspect of the question. However, co
Context (PECO)
Answers these questions
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created